About Biopredic Advancells
Biopredic Advancells is a Healthcare company based in Noida (India) founded in 2019 by Vipul Jain. It produces and distributes primary cells and tissues for research and drug testing. It operates on a B2B model. Its Indian entity Biopredic Advancells Private Limited reported revenue of ₹1.51 Cr. Biopredic Advancells offers products and services including Primary Cells, HepaRG™ Cell Line, and Tissues and Fluids. Its focus areas include Health Tech, Biotech, Drug Development and Toxicology Products.
Company details
Biopredic Advancells Pvt. Ltd., based in Noida, India, is a joint venture between French and Indian firms, specializing in biological solutions for translational medicine. They produce and distribute primary cells, cell lines, tissues, and reagents for drug development, toxicology, and cosmetics research. Serving academic institutions and industrial clients like CROs and pharmaceutical companies, they support in vitro studies to replace animal testing, ensuring cost-effective and replicable products.
- Headquarters Noida, India
- Founders Vipul Jain
- SectorsHealthcare
- Phone•••• ••••
- Website biopredicadvancells.com
- Social LinkedIn
- Legal Name Biopredic Advancells Private Limited
- Date of Incorporation 01 Aug, 2019
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹1.51 Cr
FY 2025 · +46% YoY
- Net Profit₹46.1 Lakh
FY 2025 · 30% margin
- EBITDA₹61.9 Lakh
FY 2025 · 41% margin
Associated legal entities of Biopredic Advancells
Biopredic Advancells operates through Biopredic Advancells Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biopredic Advancells Private Limited CIN U73200DL2019FTC353357 | Active | 01 Aug 2019 | New Delhi, Delhi | ₹1.5 Cr | 2 | View details |
Products & Services of Biopredic Advancells
Biopredic Advancells offers a comprehensive portfolio of products and services, including Primary Cells, HepaRG™ Cell Line, and Tissues and Fluids.
Customized cells for drug research and toxicology studies.
Hepatic stem cell line for in vitro toxicology testing.
Samples for pharmacokinetics and biomarker studies.
Board of directors of Biopredic Advancells Private Limited (Biopredic Advancells)
Biopredic Advancells Private Limited is the primary company behind Biopredic Advancells. The board of Biopredic Advancells Private Limited currently have 2 directors; the longest-serving is Christophe Chesne, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Christophe Chesne DIN 08514344 | Director | 01 Aug 2019 | 7 yrs 3 mo | Biopredic Advancells Private Limited |
| Vipul Jain DIN 01203499 | Director | 01 Aug 2019 | 7 yrs 3 mo | Biopredic Advancells Private Limited |
People of Biopredic Advancells
1 people are tracked at Biopredic Advancells (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder, Managing Director | Leadership |
Complete people profiles for Biopredic Advancells
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Biopredic Advancells
Figures of Biopredic Advancells Private Limited, the primary company behind Biopredic Advancells, for FY 2025. Revenue was ₹1.51 Cr (+46% year on year). Net profit was ₹46.1 Lakh (30% margin). EBITDA was ₹61.9 Lakh (41% margin). Revenue has grown at a compounded annual rate of +28% over three years.
- ₹1.51 CrRevenue · FY 2025 · +46% YoY
- ₹46.1 LakhNet profit · 30% margin
- ₹61.9 LakhEBITDA · 41% margin
- ₹17 LakhPaid-up capital
- +28%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Biopredic Advancells Private Limited are on its company page.
Detailed financial statements for Biopredic Advancells
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biopredic Advancells
Biopredic Advancells was founded in 2019.
Biopredic Advancells is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
The primary company behind Biopredic Advancells, Biopredic Advancells Private Limited, reported revenue of ₹1.51 Cr for FY 2025, up 46% year on year.
Biopredic Advancells Pvt. Ltd., based in Noida, India, is a joint venture between French and Indian firms, specializing in biological solutions for translational medicine. They produce and distribute primary cells, cell lines, tissues, and reagents for drug development, toxicology, and cosmetics research. Serving academic institutions and industrial clients like CROs and pharmaceutical companies, they support in vitro studies to replace animal testing, ensuring cost-effective and replicable products.
Biopredic Advancells offers Primary Cells, HepaRGâ„¢ Cell Line, and Tissues and Fluids.
Biopredic Advancells operates through Biopredic Advancells Private Limited.
The legal entities of Biopredic Advancells currently have 2 directors, including Christophe Chesne, Vipul Jain.